GSCGreen and Sustainable Chemistry2160-6951Scientific Research Publishing10.4236/gsc.2015.54017GSC-61104ArticlesChemistry&Materials Science Synthesis of New Mannich Products Bearing Quinoline Nucleous Using Reusable Ionic Liquid and Antitubercular Evaluation itendraM. Patel1*Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, India* E-mail:hmpatel7171@gmail.com1611201505041371442 October 2015accepted 13 November 16 November 2015© Copyright 2014 by authors and Scientific Research Publishing Inc. 2014This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/

A series of Mannich products bearing quinoline nucleus was synthesized, characterized, and evaluated for their in vitro antitubercular activity against Mycobacterium tuberculosis H 37Rv. The results showed that compounds 4b, and 4d found most active with percentage inhibition of 95, and 96, respectively, at minimum inhibitory concentration (MIC) of >6.25 μg/mL, among the synthesized compounds. Whereas, compounds 4a, 4c, 4e, and 4f exhibited considerable antitubercular activity with percentage inhibition of 71, 79, 55, and 68, respectively, at MIC of >6.25 μg/mL. The structures of synthesized compounds were elucidated by various spectroscopic tools like IR, 1H NMR, 13C NMR, mass and elemental analysis.

Antitubercular Activity Green Synthesi Mannich Products <i>Mycobacterium tuberculosis</i> Quinoline Spectroscopic Tools1. Introduction

Tuberculosis (TB) is a global epidemic and an infectious disease caused by the pathogenic bacterium Mycobacterium tuberculosis (Mtb) [1] . According to the most recent World Health Organization (WHO) report on TB, there are estimated 8.6 million new cases and 1.3 million deaths from the disease, including 320,000 deaths among HIV-infected people in 2012 [2] . Among them, the vast majority of TB cases are reported in the Asian, African, and western Pacific regions. India and China together account for 40% of total cases [2] that represent that TB is no more disease of rich countries. Moreover, development of new virulent forms of TB, such as multidrug resistant ([MDR-TB, resistant to at least two frontline drugs such as isoniazid (INH) and rifampin (RIF)]) and extremely drug resistant (XDR-TB), and its synergistic effects with human immunodeficiency virus (HIV) have become a major threat to human kind [3] - [6] . TB is at its peak recent years, largely owing to HIV infection, immigration, increased trade, and globalization [7] . The increasing occurrence of drug-resistant TB, especially multidrug-resistant TB, is particularly alarming. MDR-TB has already caused several lethal outbreaks [8] and has posess a substantial peril to the treatment and control of the disease in several parts of the globe, where the incidence of MDR -TB can be as high as 14% [7] . There is much apprehension that the TB situation may become even shoddier with the spread of HIV globally, a virus that significantly weakens the host immune system and allows latent TB to reactivate and makes the victim more vulnerable to reinfection with either drug-susceptible or drug-resistant strains. The fatal combination of drug-resistant TB and HIV infection is a growing problem that presents serious challenges for effective TB control. In view of this situation, in 1993 the WHO declared TB a global emergency [9] .

Over the past few decades, Mannich bases of heterocyclic molecules have found to show versatile pharmacological activities [10] - [12] . In addition to this, various quinoline containing molecules have been synthesized tested for anti-TB activity all over the world. D. Sriram et al. [13] synthesized 48 novel 6-nitroquinolone-3- carboxylic acids derivatives and compound having sustitution (4-((benzo [d] [1] [3] dioxol-5-yl) methyl) piperazin-1-yl) was found to be the most active compound in vitro with MIC of 0.08 and 0.16 μM against MTB and MDR-TB, respectively. They also extend their work to synthesized various 2-(sub)-3-fluoro/5-nitro-1,2-dihydro- 5-oxobenzothiazolo [3,2-a] quinoline-6-carboxylic acid and evaluate for in-vitro against Mycobacterium tuberculosis H37Rv (MTB), multi-drug resistant Mycobacterium tuberculosis (MDR-TB), and Mycobacterium smegmatis (MC2). Compound bearing 2-(3-(diethylcarbamoyl) piperidin-1-yl)-) is found to be the most active compound with MIC of 0.18 and 0.08 μM against MTB and MTR-TB [14] . 3D-QSAR analysis has been employed by Rahul Jain and co-worker to understand the relationship between structure and anti-TB activity. They develop new 4-(adamantan-1-yl)-2-substituted quinolines derivatives, the most potent analog of the series produces 99% inhibition at 1.00 μg/mL against drug-sensitive strain, and MIC of 3.125 μg/mL against isoniazid resistant TB strain [15] .

Recognizing these facts and continuation of our earlier work based on u. v. absorbing materials as well as heterocyclic moiety [16] - [28] , we set upon a program of achieving significant antitubercular molecules, using phenol aldehyde and various amide derivatives to achieve Mannich products bearing quinoline nucleus.

2. Materials and Methods2.1. Materials

Melting points were determined in open capillary tubes and are uncorrected. Formation of the compounds was routinely checked by TLC on silica gel-G plates of 0.5 mm thickness and spots were located by iodine. IR spectra were recorded Shimadzu FT-IR-8400 instrument using KBr pellet method. Mass spectra were recorded on Shimadzu GC-MS-QP-2010 model using Direct Injection Probe technique. 1H NMR and 13C NMR spectra were determined in DMSO-d6 solution on a Bruker Ac 400 MHz spectrometer. Elemental analysis of the all the synthesized compounds was carried out on Elemental Vario EL III Carlo Erba 1108 model and the results were in agreements with the structures assigned. All chemicals were purchased from commercial sources and used without further purification.

2.2. Synthetic Procedures for Synthesis of Substituted Mannich Products Bearing Quinoline Nucleous (4a-f)

A mixture of 2,4-dihydroxybenzophenone 1.07 gm (0.005 M), 2-chloro-6-methoxyquinoline-3-carboxaldehyde 1.105 gm (0.005 M), various amides 0.30 gm (0.005 M) and EAN 30 ml (1 M) was refluxed with stirring at 80˚C temperature. The completion of reaction was monitored by TLC with using solvent system chloroform/methanol (v/v = 70:30). On completion of reaction, the reaction mixture was extracted thrice with 20 ml ethyl acetate. The extract was dried over anhydrous sodium sulfate, evaporated under vacuum and the residue was purified via recrystallisation from methanol or ethyl acetate to obtain pure new Mannich products 4(a-f) (Scheme 1).

2.3. Spectroscopic Data for New Mannich Products (4a-f)

1-((5-benzoyl-2,4-dihydroxyphenyl) (2-chloro-6-methoxyquinolin-3-yl) methyl) urea (4a)

Scheme 1. Synthesis of new Mannich products 4(a-f) bearing quinolinenucleous.

It was obtained as yellow solid color, yield: 84%; decomposition temperature 188˚C - 192˚C; IR (KBr, υmax/cm−1): 3463, 3440 (Ar-OH), 3198 (-NH), 3072 (CH, aromatic), 2974, 741 (CH aliphatic), 1705, 1628 (C=O, diaryl), 1605 (C=N), 1519 (C-N), 1481 (C-C, aromatic), 1212-1024 (C-O-C), 1101 (C-O), 732, 584 (for substituted benzene); 1H-NMR (CDCl3, 400 MHz): δ = 8.25-7.01 (4H, m, H-4, H-5, H-7, H-8, -CH for substituted quinoline), 7.97 (1H, s, Ar-OH, -intra), 7.84 (1H, d, J = 7.8 Hz, -NHCO-), 7.01-7.78 (7H, m, H-3’, H-6’, H-2”, H-3”, H-4”, H-5”, H-6”, Ar-H), 7.01 (1H, s, Ar?OH), 7.05 (1H, dd, J = 10.5, 3.5 Hz, -CHNH), 6.86 (2H, s, -CONH2), 4.06 (3H, s, -OMe); 13C NMR (CDCl3, 400 MHz,): δ = 203.1 (C, -C=O, benzoyl), 163.2 (C-4’, Ar-OH), 160.1 (C, NHCONH2),159.4, (C-2’, Ar-OH), 155.9 (C-6, C-OCH3), 150.2 (C-2,C-Cl), 148.6 (C, C-10), 132.7 (C, C-1”), 132.2 (C, C-9), 132.0 (C, C-8), 131.8 (C, C-4), 131.7 (C, C-1’), 131.6 (C, C-6), 130.5 (2C, C-2” & C-6”), 128.1 (C, C-4’), 122.8 (2C, C-3”& C-5”), 119.7 (C, C-5’), 109.4 (C, C-7), 107.5 (C, C-5), 104.1 (C, C-3’), 101.8 (C, C-3), 55.2 (C, -OCH3), 51.2 (C, aliphatic-CH); EI-MS m/z: 477 (M+1)+; Anal. Calc. for C25H20ClN3O5 (%): C, 62.83; H, 4.22; N, 8.79% found: C, 62.80; H, 4.19; N, 8.71%.

1-((5-benzoyl-2,4-dihydroxyphenyl) (2-chloro-6-methoxyquinolin-3-yl) methyl) thiourea (4b)

It was obtained as pale yellow solid color, yield: 88%; decomposition temperature 180-1840C; IR (KBr, υmax/cm−1): 3463, 3440 (Ar-OH), 3198 (-NH), 3072 (CH, aromatic), 2974, 741 (CH aliphatic), 1705, 1630 (C=O, diaryl), 1605 (C=N), 1519 (C-N), 1481 (C-C, aromatic), 1329 (C=S), 1212-1024 (C-O-C), 1101 (C-O), 732, 584 (for substituted benzene), 691 (C-S); 1H-NMR (CDCl3, 400 MHz,): δ = 8.25 - 7.25 (4H, m, H-4, H-5, H-7, H-8, -CH for substituted quinoline), 7.97 (1H, s, Ar-OH, -intra), 7.85 (1H, d, J = 7.8 Hz, -NH), 7.2-7.78 (7H, m, H-3’, H-6’, H-2”, H-3”, H-4”, H-5”, H-6”, Ar-H), 7.01 (2H, s, -CSNH2), 6.76 (1H, s, Ar-OH), 5.96 (1H, dd, J = 10.5, 3.5 Hz, -CHNH), 4.08 (3H, s, -OMe); 13C NMR (CDCl3, 400 MHz,): δ = 203.1 (C, -C=O, benzoyl), 176.5 (C, NHCSNH2), 166.0 (C-4’, Ar-OH), 158.7(C-2’, Ar-OH), 155.8 (C-6, C-OCH3), 152.1 (C-2, C-Cl), 150.0 (C, C-10), 135.4 (C, C-1”), 135.2 (C, C-9), 133.3 (C, C-8), 132.9 (C, C-4), 132.4 (C, C-1’), 131.9 (C, C-6), 131.7 (2C, C-2” & C-6”), 1128.6 (C, C-4’), 124.0 (2C, C-3” & C-5”), 122.1 (C, C-5’), 112.9 (C, C-5), 112.4 (C, C-3), 103.9 (C, C-7), 103.5 (C, C-3”), 57.4 (C, -OCH3), 55.2 (C, aliphatic-CH); EI-MS m/z: 493 (M+1)+; Anal. Calc. for C25H20ClN3O4S (%): C, 60.79; H, 4.08; N, 8.51%; found: C, 60.72; H, 4.03; N, 8.47%.

2-((5-benzoyl-2,4-dihydroxyphenyl) (2-chloro-6-methoxyquinolin-3-yl) methyl) hydrazine carboxamide (4c)

It was obtained as yellowish green solid color, yield: 82%; decomposition temperature 260˚C - 264˚C; IR (KBr, υmax/cm−1): 3463, 3440 (Ar-OH), 3198 (-NH), 3072 (CH, aromatic), 2974, 741 (CH aliphatic), 1705, 1629 (C=O, diaryl), 1605 (C=N), 1519 (C-N), 1481 (C-C, aromatic), 1212-1024 (C-O-C), 1101 (C-O), 732, 584 (for substituted benzene); 1H-NMR (CDCl3, 400 MHz,): δ = 8.25 (1H, s, Ar-OH, -intra), 7.97-7.55 (4H, m, H-4, H-5, H-7, H-8, -CH for substituted quinoline), 7.84 (1H, d, J = 7.8Hz, -NHNHCO-), 7.68-7.15 (7H, m, H-3’, H-6’, H-2”, H-3”, H-4”, H-5”, H-6”, Ar-H), 7.45 (1H, d, J = 8.1 Hz, -NHNHCO), 7.44 (2H, s, -CONH2), 7.03 (1H, s, Ar-OH), 6.69 (1H, dd, J = 10.5, 3.5 Hz, -CHNH), 3.96 (3H, s, -OMe); 13C NMR (CDCl3, 400 MHz,): δ = 203.1 (C, -C=O, benzoyl), 163.9 (C-4’, Ar-OH), 160.1 (C-2’, Ar-OH), 159.4 (C, -NHNHCONH2), 155.2 (C-6, C-OCH3), 150.7 (C-2,C-Cl), 148.1 (C, C-10), 132.4 (C, C-1”), 132.2 (C, C-9), 132.0 (C, C-8), 131.8 (C, C-4”), 131.4 (C, C-1’), 131.2 (C, C-6), 130.3 (2C, C-2” & C-6”), 128.8 (C, C-4), 122.4 (2C, C-3” & C-5”), 119.9 (C, C-5’), 109.2 (C, C-5), 107.9 (C, C-3’), 104.1 (C, C-7), 101.1 (C, C-3), 55.2 (C, -OCH3), 51.2 (C, aliphatic-CH); EI-MS m/z: 492 (M+1)+; Anal. Calc. for C25H21ClN4O5 (%): C, 60.92; H, 4.29; N, 11.37; %; found: C, 60.89; H, 4.22; N, 11.32%.

2-((5-benzoyl-2,4-dihydroxyphenyl) (2-chloro-6-methoxyquinolin-3-yl) methyl) hydrazinecarbothioamide (4d)

It was obtained as pale yellow color, yield: 86%; decomposition temperature 176˚C - 180˚C; IR (KBr, υmax/cm−1): 3463, 3440 (Ar-OH), 3198 (-NH), 3072 (CH, aromatic), 2974, 741 (CH aliphatic), 1705, 1633 (C=O, diaryl), 1605 (C=N), 1519 (C-N), 1481 (C-C, aromatic), 1329 (C=S), 1212-1024 (C-O-C), 1101 (C-O), 732, 584 (for substituted benzene), 690 (C-S); 1H-NMR (CDCl3, 400 MHz): δ = 8.20-7.14 (4H, m, H-4, H-5, H-7, H-8, -CH for substituted quinoline), 7.98 (2H, s, -CSNH2), 7.85 (1H, s, Ar-OH, -intra), 7.78-6.48 (7H, m, H-3’, H-6’, H-2”, H-3”, H-4”, H-5”, H-6”, Ar-H), 7.44 (1H, dd, J = 7.8Hz, -NHNHCS-), 6.99 (1H, dd, J = 8.1 Hz, -NHNHCS-), 6.79 (1H, s, Ar-OH), 6.00 (1H, dd, J = 10.5, 3.5 Hz, -CHNH), 3.96 (3H, s, -OMe); 13C NMR (CDCl3, 400 MHz): δ = 203.13 (C, -C=O, benzoyl), 176.1 (C, -NHNHCSNH2), 166.7 (C-4’, Ar-OH), 158.8 (C-2’, Ar-OH), 155.8 (C-6, C-OCH3), 152.9 (C-2, C-Cl), 150.2 (C, C-10), 135.3 (C, C-1”), 135.2 (C, C-9), 133.1 (C, C-8), 132.6 (C, C-4”), 132.3 (C, C-1’), 131.4 (C, C-6’), 131.0 (2C, C-2” & C-6”), 128.4 (C, C-4), 124.8 (2C, C-3” & C-5”), 122.9 (C, C-5’), 112.6 (C, C-5), 112.1 (C, C-3), 103.4 (C, C-7), 103.2 (C, C-3’), 57.4 (C, -OCH3), 55.2 (C, aliphatic-CH-); EI-MS m/z: 508 (M+1)+; Anal. Calc. for C25H21ClN4O4S (%): C, 58.99; H, 4.16; N, 11.01; %. found: C, 58.93; H, 4.12; N, 10.06%.

N-((5-benzoyl-2,4-dihydroxyphenyl) (2-chloro-6-methoxyquinolin-3-yl) methyl) acetamide (4e)

It was obtained as yellowish green color, yield: 89%; decomposition temperature 216˚C - 220˚C; IR (KBr, υmax/cm−1): 3463, 3440 (Ar-OH), 3198 (-NH), 3072 (CH, aromatic), 2974, 741, 650 (CH aliphatic), 1705, 1628 (C=O, diaryl), 1605 (C=N), 1519 (C-N), 1481 (C-C, aromatic), 1212-1024 (C-O-C), 1101 (C-O), 732, 584 (for substituted benzene); 1H-NMR (CDCl3, 400 MHz): δ = 8.85-6.83 (4H, m, H-4, H-5, H-7, H-8, -CH for substituted quinoline), 7.87 (1H, s, Ar-OH), 7.84 (1H, d, J = 7.8 Hz, -NHCO-), 7.68-6.78 (7H, m, H-3’, H-6’, H-2”, H-3”, H-4”, H-5”, H-6”, Ar-H), 6.47 (1H, s, Ar-OH), 6.60 (1H, dd, J = 10.5, 3.5 Hz, -CHNH), 4.00 (3H, s, -OMe), 1.84 (3H, s, -CH3); 13C NMR (CDCl3, 400 MHz): δ = 203.1 (C, -C=O, benzoyl), 169.4 (C, C=O, acetamide), 166.5 (C-4’, Ar-OH), 157.9 (C-2’, Ar-OH), 154.2 (C-6, C-OCH3), 152.0 (C-2, C-Cl), 150.2 (C, C-10), 135.4 (C, C-1”), 135.3 (C, C-9), 132.3 (C, C-8), 132.0 (C, C-4”), 131.6 (C, C-1’), 130.1 (C, C-6’), 129.8 (2C, C-2” & C-6”), 128.1 (C, C-4), 124.7 (2C, C-3” & C-5”), 122.8 (C, C-5’), 112.1 (C, C-5), 109.8 (C, C-3), 102.6 (C, C-7), 102.2 (C, C-3), 55.2 (C, -OCH3), 39.3 (C, aliphatic-CH), 23.9 (C,-CH3); EI-MS m/z: 476 (M+1)+; Anal. Calc. for C26H21ClN2O5 (%): C, 65.48; H, 4.44; N, 5.87%; found: C, 65.46; H, 4.41; N, 5.82%.

N-((5-benzoyl-2,4-dihydroxyphenyl) (2-chloro-6-methoxyquinolin-3-yl) methyl) benzamide (4f)

It was obtained as yellowish green color, yield: 85%; decomposition temperature 188˚C - 192˚C; IR (KBr, υmax/cm−1): 3463, 3440 (Ar-OH), 3198 (-NH), 3072 (CH, aromatic), 2974, 741 (CH aliphatic), 1705, 1627 (C=O, diaryl), 1605 (C=N), 1519 (C-N), 1481 (C-C, aromatic), 1212-1024 (C-O-C), 1101 (C?O), 732, 584 (for substituted benzene); 1H?NMR (CDCl3, 400 MHz): δ = 9.23 (1H, d, NH), 7.14-8.20 (4H, m, H-4, H-5, H-7, H-8,-CH for substituted quinoline), 6.48-8.03 (12H, m, H-3’, H-6’, H-2”, H-3”, H-4”, H-5”, H-6”, H-2”’, H-3”’, H-4”’, H-5”’, H-6”’, Ar-H), 6.16 (1H, dd, J = 10.5, 3.5Hz, -CHNH), 5.35 (2H, s, Ar-OH), 3.83 (3H, s, -OMe); 13C NMR (CDCl3, 400 MHz): δ = 203.1 (C, -C=O, benzoyl), 168.1 (C, -C=O, NHCOC6H5), 166.6 (C-4’, Ar-OH), 157.9 (C-2’, Ar-OH), 154.2 (C-6, C-OCH3), 152.0 (C-2, C-Cl), 150.2 (C, C-10), 137.1 (C, C-1”), 135.4 (C, C-9), 135.0 (C, C-8), 132.2 (C, C-4”), 131.6 (C, C-4”’), 130.7 (C, C-1’), 130.1 (C, C-6), 129.9 (2C , C-2” & C-6”), 129.8 (C, C-4), 129.5 (2C, C-3”’ & C-5”’), 128.1 (2C, C-2’” & C-6”’), 126.4 (C, C-5’), 124.2, (C,C-3” & C-5”) 122.8 (C, C-1”’), 111.6 (C, C-5), 109.8 (C, C-3), 102.6 (C, C-7), 102.2 (C, C-3’ & C-6’), 55.2 (C, -OCH3), 41.5 (C, aliphatic-CH); EI-MS m/z: 538 (M+1)+; Anal. Calc. for C31H23ClN2O5 (%): C, 69.08; H, 4.30; N, 5.20%; found: C, 69.01; H, 4.27; N, 5.17%.

2.4. Antituberculosis Activity

All the newly synthesized compounds were evaluated for their in vitro antitubercular activity at the Tuberculosis Acquisition Antimicrobial Coordinating Facility (TAACF) screening program, Alabama, USA. Minimum inhibitory concentration (MIC) was determined against Mycobacterium tuberculosis H37Rv by using the radiometric BACTEC [29] and broth dilution [30] assay methods.compounds 4b, and 4d found most active with percentage inhibition of 95, and 96, respectively, at minimum inhibitory concentration (MIC) of 6.25 µg/mL, among the synthesized compounds. Whereas compounds 4a, 4c, 4e, and 4f exhibited considerable antitubercular activity with percentage inhibition of 71, 79, 55, and 68, respectively, at MIC of >6.25 µg/mL. The results of in vitro antitubercular screening of newly synthesized phenothiazines bearing nitrogen mustard are presented in Table 1.

3. Results and Discussion

The promising results obtained on 2-chloro-6-methoxyquinoline-3-carboxaldehyde, 2,4-dihydroxybenzophe-

Invitroantitubercular screening data in µg/mL of (4a-f)
CompoundsRMolecular FormulaMIC µg/mL% Inhibition
4aCONH2C25H20ClN3O5>6.2571
4bCSNH2C25H20ClN3O4S>6.2595
4cNHCONH2C25H21ClN4O5>6.2579
4dNHCSNH2C25H21ClN4O4S>6.2594
4eCOCH3C26H21ClN2O5>6.2555
4fCOC6H5C31H23ClN2O5>6.2568

none and various amides using 1 M EAN as catalyst at the 80˚C temperature encouraged us to investigate the feasibility of solvent-free MCRs protocol to a wide range of chloro substituted aldehydes, amides/carbamates/ urea and 2,4-dihydroxybenzophenone for the synthesis of new Mannich products 4(a-f).

A bromo derivative of hetrocyclic aldehydes, amides/carbamates/urea possessing various electron donating and electron withdrawing functional groups reacted smoothly with 2,4-dihydroxybenzophenone under neat reaction conditions to give desired products in excellent yields over EAN at 80˚C temperature. The results illustrate that the one-pot three component condensation reactions show excellent performance irrespective of the presence of electron withdrawing or electron donating groups on aromatic/hetrocyclic aldehydes and hence solvent- free MCRs protocol is highly effective, promising and general for the synthesis of new Mannich products 4a-f. The substituted aromatic aldehydes with electron withdrawing group reacted with 2,4-dihydroxybenzophe-none and different amides provided desired products in excellent yields. The recovery and recyclability of EAN was still investigated for the synthesis of new Mannich products 4(a-f) by one-pot three component condensations of above said aldehyde, phenol and different amide as model substrates in the presence of EAN is under progress. The high yield of new Mannich products 4(a-f) using EAN at milder reaction condition compared to other ionic liquid can be rationalized due to high acidity associated with it (pH = 5) along with its capacity to absorb water formed during course of the reaction.

All the synthesized compounds 4(a-f) were purified by re-crystallization with suitable solvents and characterized by spectral FT-IR, 1H-NMR, 13C-NMR and elemental analysis. The results of elemental analyses of each new Mannich products 4(a-f) were consistent with the predicted structure, as shown in Scheme 1 and Table 1. The IR, 1H-NMR, 13C-NMR spectrum of each compounds comprised the important features of aromatic, methoxy, hydroxyl, keto and chloro and different amide groups. The IR spectra of all compound 4(a-f) showed absorption band at around 3463, 3198, 3072, 2974, 741, 1705, 1628, 1605, 1519, 1481, 1212-1024, 1101, 732, 584 cm−1 regions, conforming the groups presence in each compounds are retained. In all compounds, phenolic -OH group gives absorption band between 3450 to 3463 cm−1 and carbonyl groups of diaryl shows 1620 to 1628 cm−1. Mannich product has characteristic functional group (-CH-) which shows band at 3032 to 3066 cm−1. The presence of aliphatic (-CH group) in each compound shows 1H-NMR spectra 6.16 δ is confirmed obtained Mannich reaction. The 1H-NMR spectra of all the new compounds based on 2,4-dihydroxybenzophenone, chloroderivatives of quinoline and amide group show important signals at their respective positions, confirming the structures of 4(a-f), as shown in Scheme 1 and Table 1. Methyl group protons gave a singlet between 1.84 δ ppm in compounds 4e, Out of two hydroxy groups in all compounds, one -OH shows signals at 5.35 δ where as another -OH gives signals between 7.8 to 8.25 δ which confirmed the intramolecular hydrogen bonding. As far as -OCH3 group is concern it appears at4.06. 4c and 4d compounds having -NH group gives doublet signals between 7.8 to 8.0 δ and -NH of amide group shows signals at 7.8 δ. 13C-NMR spectra of all compounds showed characteristic signals appearing for aliphatic -CH is 47.2 to 54.8 δ which confirmed the all new Mannich products 4(a-f). Another groups also appears as 106.6 δ for C-Cl, 157.2 δ for methoxy group (C-OCH3), 158.2 to 159.7 δ for phenolic (C-OH). Amide andthioamide appears at 159.9 (CONH2) and 184.3 δ (CSNH2) respectively. In the case of semicarbazide and thiosemicarbazide for 4c and 4d appears at 154.6 and 170.8 δ. Carbonyl and methoxy group of all compounds 4(a-f) shows 198.6 δ and 55.8 δ respectively. The results of spectral analysis indicated that the compounds are pure.

The results from in vitro antitubercular screening against Mycobacterium tuberculosis H37Rv were very much encouraging. It may be predicted that Mannich base linkange would increase the lipophilicity of molecule hence help molecule to penetrate in the mycobacterium cell wall, and quinoline would generate reactive oxygen species. The compounds 4b and 4d found most active with percentage inhibition of 95 and 94, respectively, at minimum inhibitory concentration (MIC) of 6.25 µg/mL, among the synthesized compounds. Whereas, compounds 4a, 4c, 4d, and 4e, exhibited considerable antitubercular activity with percentage inhibition of 71, 79, 55, and 68, respectively, at MIC of >6.25 µg/mL. On evaluation of antitubercular screening data, it can be seen that extent of percentage inhibition is largely affected by the type of substitutions at phenyl ring irrespective of positions of substitution. Electron withdrawing group at phenyl ring considerably enhanced the antitubercular activity whereas electron releasing groups on phenyl ring strongly diminished the antitubercular activity, which can be evident by antitubercular screening results.

4. Conclusion

In the present paper, we report the synthesis, characterization and antitubercular activity of new Mannich products bearing quinoline moiety. The results indicate that quinoline moiety with increased lipophilicity and ability of Benzophenone to general reactive oxygen species make the molecule suitable candidate against Mycobacterium tuberculosis. The promising results from antitubercular screening make quinoline moiety as important class in the area of tuberculosis research. Moreover, incorporation of quinoline moiety will offer new possibilities of this class apart from conventional biological activities.

Acknowledgements

This work was funded by University Grant Commission, New Delhi, and File No. 41-300/2012 (SR). The authors wish to thank UGC for its financial support to the scheme. The authors are indebted to Micro Care Lab for biological tests. Authors are also thankful to C.V.M. for providing research facility.

Cite this paper

Hitendra M. Patel, (2015) Synthesis of New Mannich Products Bearing Quinoline Nucleous Using Reusable Ionic Liquid and Antitubercular Evaluation. Green and Sustainable Chemistry,05,137-144. doi: 10.4236/gsc.2015.54017

ReferencesZumla, A., George, A., Sharma, V., Herbert, N. and Baroness, I. (2013) Masham of Ilton. The Lancet, 382, 1765-1767. http://dx.doi.org/10.1016/S0140-6736(13)62078-4World Health Organization (2013) Global Tuberculosis Report. World Health Organization. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656Abubakar, I., Zignol, M., Falzon, D., Raviglione, M., Ditiu, L., Masham, S., Adetifa, I., Ford, N., Cox, H., Lawn, S.D., Marais, B.J., McHugh, T.D., Mwaba, P., Bates, M., Lipman, M., Zijenah, L., Logan, S., McNerney, R., Zumla, A., Sarda, K., Nahid, P., Hoelscher, M., Pletschette, M., Memish, Z.A., Kim, P., Hafner, R., Cole, S., Migliori, G.B., Maeurer, M., Schito, M. and Zumla, A. (2013) Drug-Resistant Tuberculosis: Time for Visionary Political Leadership. The Lancet Infectious Diseases, 13, 529-539. http://dx.doi.org/10.1016/S1473-3099(13)70030-6Lawn, S.D., Mwaba, P., Bates, M., Piatek, A., Alexander, H., Marais, B.J., Cuevas, L.E., McHugh, T.D., Zijenah, L., Kapata, N., Abubakar, I., McNerney, R., Hoelscher, M., Memish, Z.A., Migliori, G.B., Kim, P., Maeurer, M., Schito, M. and Zumla, A. (2013) Advances in Tuberculosis Diagnostics: the Xpert MTB/RIF Assay and Future Prospects for a Point-of-Care Test. The Lancet Infectious Diseases, 13, 349-361. http://dx.doi.org/10.1016/S1473-3099(13)70008-2Prabowo, S.A., Groschel, M.I., Schmidt, E.D., Skrahina, A., Mihaescu, T., Hasturk, S., Mitrofanov, R., Pimkina, E., Visontai, I., de Jong, B., Stanford, J.L., Cardona, P.J., Kaufmann, S.H. and vander Werf, T.S. (2013) Targeting Multidrug-Resistant Tuberculosis (MDR-TB) by Therapeutic Vaccines. Medical Microbiology and Immunology, 202, 95-104. http://dx.doi.org/10.1007/s00430-012-0278-6Falzon, D., Jaramillo, E., Schünemann, H., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J., Daley, C. and Duncombe, C. (2011) WHO Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: 2011 Update. European Respiratory Journal, 38, 516-528. http://dx.doi.org/10.1183/09031936.00073611World Health Organization (2003) The World Health Organization Global Tuberculosis Program. http://www.who.int/gtb/Espinal, M.A. (2003) The global situation of MDR-TB. Tuberculosis, 83, 44-51. http://dx.doi.org/10.1016/S1472-9792(02)00058-6Parrish, N.M., Dick, J.D. and Bishai, W.R. (1998) Mechanisms of Latency in Mycobacterium tuberculosis. Trends in Microbiology, 6, 107-112. http://www.sciencedirect.com/science/article/pii/S0966842X98012165 http://dx.doi.org/10.1016/S0966-842X(98)01216-5Vijayraghavan, S., Somani, R., Shirodkar, P. and Kadam, V. (2009) Microwave Assisted Synthesis and Antimicrobial Activity of Some Newer Mannich Bases. International Journal of PharmTech Research, 3, 811-815. http://www.sphinxsai.com/PTVOL3/PT=64,Rakesh%20Somani%20(811-815).pdfJoshi, S., Khosla, N. and Tiwari, P. (2004) In vitro Study of Some Medicinally Important Mannich Bases Derived from Antitubercular Agent. Bioorganic & Medicinal Chemistry, 12, 571-576. http://www.ncbi.nlm.nih.gov/pubmed/14738966 http://dx.doi.org/10.1016/j.bmc.2003.11.001Sriram, D., Yogeswari, P. and Reddy, S. (2006) Synthesis of Pyrazinamide Mannich Bases and Its Antitubercular Properties. Bioorganic & Medicinal Chemistry, 16, 2113-2116. http://www.ncbi.nlm.nih.gov/pubmed/16464574 http://dx.doi.org/10.1016/j.bmcl.2006.01.064Senthilkumar, P., Dinakaran, M., Yogeeswari, P., Sriram, D., China, A. and Nagaraja, V. (2009) Synthesis and Antimycobacterial Activities of Novel 6-Nitroquinolone-3-Carboxylic Acids. European Journal of Medicinal Chemistry, 44, 345. http://www.ncbi.nlm.nih.gov/pubmed/18502542 http://dx.doi.org/10.1016/j.ejmech.2008.02.031Dinakaran, M., Senthilkumar, P., Yogeeswari, P., China, A., Nagaraja, V. and Sriram, D. (2008) Novel Ofloxacin Derivatives: Synthesis, Antimycobacterial and Toxicological Evaluation. Bioorganic & Medicinal Chemistry Letters, 18, 1229-1236. http://www.ncbi.nlm.nih.gov/pubmed/18068979 http://dx.doi.org/10.1016/j.bmcl.2007.11.110Nayyar, A., Monga, V., Malde, A., Coutinho, E. and Jain, R. (2007) Synthesis, Anti-Tuberculosis Activity, and 3D-QSAR Study of 4-(Adamantan-1-yl)-2-substituted Quinolines. Bioorganic & Medicinal Chemistry, 15, 626-640. http://dx.doi.org/10.1016/j.bmc.2006.10.064Patel, H.M. (2014) International Journal of Scientific & Engineering Research, 5, 2213-2217. http://www.recentscientific.com/sites/default/files/download_168.pdfPatel, H.M. (2014) Synthesis, Structure Investigation and Dyeing Assessment of Novel Bisazo Disperse Dyes Derived from UV Absorbing Materia. IOSR Journal of Applied Chemistry, 6, 51-55. http://iosrjournals.org/iosr-jac/papers/vol6-issue5/E0655155.pdfDixit, B.C., Patel, H.M., Dixit, R.B., Desai, D.J. (2007) Synthesis and Application of New Mordent and Disperse Azo Dyes Based on 2,4-Dihydroxybenzophenone. Journal of the Serbian Chemical Society, 72, 119-127. www.doiserbia.nb.rs/ft.aspx?id=0352-51390702119D http://dx.doi.org/10.2298/JSC0702119DDixit, B.C. and Patel, H.M. (2011) Synthesis, Characterization and Printing Application of Solvent Dyes Based on 2-Hydroxy-4-n-octyloxybenzophenone. E-Journal of Chemistry, 8, 615-620. http://downloads.hindawi.com/journals/jchem/2011/862929.pdfDixit, B.C., Patel, H.M., Dixit, R.B., Desai, D.J. (2010) Synthesis, Characterization and Dyeing Assessment of Novel Acid Azo Dyes and Mordent Acid Azo Dyes Based on 2-Hydroxy-4-methoxybenzophenone on Wool and Silk Fabrics. Journal of the Serbian Chemical Society, 75, 605-614. www.doiserbia.nb.rs/ft.aspx?id=0352-51391000039DDixit, B.C., Patel, H.M., Dixit, R.B., Desai, D.J. (2009) Studies on Dyeing Performance of Novel Acid Azo Dyes and Mordent Acid Azo Dyes Based on 2,4-Dihydroxybenzophenone. E-Journal of Chemistry, 6, 315-322. https://scholar.google.co.in/scholar?q=E-Journal+of+Chemistry.+2009,+6(2),+315-322Patel, H.M. and Dixit, B.C. (2014) Synthesis, Characterization and Dyeing Assessment of novel Acid Azo Dyes and Mordent Acid Azo Dyes Based on 2-Hydroxy-4-methoxybenzophenone-5-sulfonic Acid on Wool and Silk Fabrics. Journal of Saudi Chemical Society, 18, 507-512. www.sciencedirect.com/science/article/pii/S1319610311002031 http://dx.doi.org/10.1016/j.jscs.2011.10.015Dixit, B.C. and Patel, H.M. (2010) Material Applications of Novel Disperse and Mordent Azo Dyes Based on 2-Hydroxy-4-Methoxy Benzophenone. Asian Journal of Chemistry, 22, 921-928. http://www.asianjournalofchemistry.co.in/user/journal/viewarticle.aspx?ArticleID=22_2_15Patel, H.M. (2012) Synthesis, Characterization and Dyeing Behaviour of Heterocyclic Acid Dyes and Mordent Acid Dyes on Wool and Silk Fabrics. Journal of the Serbian Chemical Society, 77, 1551-1560. www.doiserbia.nb.rs/ft.aspx?id=0352-51391200047PPatel, H.M. (2012) Synthesis, Characterization and Application of Some Novel Mordent and Heterocyclic Disperse Dyes Based on Polyester and Wool Fibers. Orbital—The Electronic Journal of Chemistry, 4, 160-170. http://www.orbital.ufms.br/index.php/Chemistry/article/view/253/pdfPatel, H.M. (2012) Material Applications of Novel Heterocyclic Disperse and Mordent Dyes Based on 2-Butyl-3-(4-hydroxybenzoyl) Benzofuran. Advances in Applied Science Research, 3, 235-241. http://pelagiaresearchlibrary.com/advances-in-applied-science/vol3-iss1/AASR-2012-3-1-235-241.pdfPatel, H.M. (2011) Synthesis, Characterization and Application of Some Novel Mordent and Heterocyclic Disperse Dyes Based on 2-Butyl-3-(4-hydroxybenzoyl) Benzofuran. Der Chemica Sinica, 2, 89-96. http://pelagiaresearchlibrary.com/der-chemica-sinica/vol2-iss6/DCS-2011-2-6-89-96.pdfPatel, H.M. (2012) Dyeing Assessment of Some Novel Mordent and Heterocyclic Disperse Dyes Based on Dihydrobenzofuran Derivatives on to Polyester and Wool Fibers. Der Chemica Sinica, 3, 175-181. http://pelagiaresearchlibrary.com/der-chemica-sinica/vol3-iss1/DCS-2012-3-1-175-181.pdfCollins, L. and Franzblau, S.G. (1997) Microplate Alamar Blue Assay versus BACTEC 460 System for High-Throughput Screening of Compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrobial Agents and Chemotherapy, 41, 1004-1009. http://aac.asm.org/content/41/5/1004.abstractYajko, D.M., Madej, J.J., Lancaster, M.V., Sanders, C.A., Cawthon, V.L., Gee, B., Babst, A. and Hadley, W.K. (1995) Colorimetric Method for Determining MICs of Antimicrobial Agents for Mycobacterium tuberculosis. Journal of Clinical Microbiology, 33, 2324-2327. http://www.ncbi.nlm.nih.gov/pubmed/7494021